Dose Escalation/Dose Expansion Study of YBL-006 in Patients With Advanced Solid Tumors

NCT04450901 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: YBL-006
DRUG: YBL-006
DRUG: YBL-006
DRUG: YBL-006
DRUG: YBL-006
DRUG: YBL-006
DRUG: YBL-006
DRUG: YBL-006

Sponsor

Y Biologics Inc.

Collaborators

[object Object]